Quarterly Activities/Appendix 5B Cash Flow Report
|
28 April 2023 at 8:30am
|
Change in substantial holding for CNJ
|
27 April 2023 at 4:00pm
|
Application for quotation of securities - TAS
|
17 March 2023 at 6:50pm
|
Half Year Accounts
|
16 March 2023 at 8:20pm
|
Change of Director's Interest Notice
|
16 March 2023 at 6:05pm
|
Change of Director's Interest Notice
|
16 March 2023 at 5:40pm
|
Application for quotation of securities - TAS
|
16 March 2023 at 2:05pm
|
Rights Issue Results
|
16 March 2023 at 1:55pm
|
Appendix 3B
|
1 March 2023 at 1:05pm
|
Extension to Closing Date of Non-Renounceable Rights Issue
|
28 February 2023 at 7:20pm
|
Application for quotation of securities - TAS
|
17 February 2023 at 3:50pm
|
Application for quotation of securities - TAS
|
10 February 2023 at 6:10pm
|
Application for quotation of securities - TAS
|
6 February 2023 at 3:35pm
|
Non Renounceable Rights Issue Offer Document
|
6 February 2023 at 9:40am
|
Cleansing Notice
|
6 February 2023 at 9:35am
|
Amended App 5B Cash Flow Report Dec'22
|
1 February 2023 at 6:45pm
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 January 2023 at 4:15pm
|
Proposed issue of securities - TAS
|
20 January 2023 at 1:10pm
|
Pro-Rata Non-Renounceable Rights Issue
|
20 January 2023 at 1:10pm
|
EDE: EdenCrete- GDOT Bridge Trial Results
|
13 January 2023 at 11:20am
|
EDE: Record Quarterly Indian OptiBlend Sales
|
9 January 2023 at 10:30am
|
Option Terms and Conditions
|
16 December 2022 at 1:35pm
|
Notification regarding unquoted securities - TAS
|
16 December 2022 at 1:25pm
|
Company Secretary Appointment/Resignation
|
16 December 2022 at 1:10pm
|
Addendum to 2022 Annual Report
|
14 December 2022 at 7:05pm
|
Eden India - Market Update
|
24 November 2022 at 10:25am
|
Results of Meeting
|
22 November 2022 at 1:40pm
|
Restructuring of US Operations
|
9 November 2022 at 11:25am
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
27 October 2022 at 6:55pm
|
Notice of Annual General Meeting/Proxy Form
|
21 October 2022 at 3:10pm
|
Appendix 4G and Corporate Governance Statement
|
30 September 2022 at 4:20pm
|
Annual Report to shareholders
|
30 September 2022 at 4:20pm
|
Application for quotation of securities - TAS
|
15 September 2022 at 2:30pm
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 July 2022 at 11:55am
|
Lake Torrens IOCG Project - Drilling Update
|
14 June 2022 at 12:25pm
|
EdenCrete now sold at select Lowe's locations
|
1 June 2022 at 9:10am
|
EdenCrete - US Market Update
|
31 May 2022 at 1:15pm
|
Fortescue to continue sole funding Lake Torrens Project
|
30 May 2022 at 9:35am
|
Change in substantial holding for CNJ
|
27 May 2022 at 1:50pm
|
CDOT Interstate 70 Vail Pass Paving Trial Update
|
27 May 2022 at 10:20am
|
Conditional Term Sheet To Restructure US Secured Debt
|
27 May 2022 at 10:20am
|
EdenCrete - Long Term Supply Agreement
|
26 May 2022 at 9:50am
|
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 April 2022 at 11:35am
|
Fortescue earns 51% in Lake Torrens Project
|
21 April 2022 at 9:20am
|
EdenCrete - A$416,050 Order for US Swimming Pool Market
|
29 March 2022 at 11:05am
|
Ceasing to be a substantial holder
|
17 March 2022 at 9:45am
|
Half Yearly Report and Accounts
|
15 March 2022 at 8:45am
|
EdenCrete - Increasing Sales for Swimming Pools - Update
|
11 March 2022 at 2:05pm
|
EdenCrete - Increased use in US swimming pools
|
4 March 2022 at 10:25am
|
First Large EdenCrete SCIP Project
|
18 February 2022 at 11:40am
|